NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis

References

• Tomkin GH , Owens D . Diabetes and dyslipidemia: characterizing lipoprotein metabolism. Diabetes Metab Syndr Obes . 2017;10:333–343. doi:10.2147/DMSO.S115855 28814891
   PubMed Web of Science ®Google Scholar
• Weber C , Noels H . Atherosclerosis: current pathogenesis and therapeutic options. Nat Med . 2011;17(11):1410–1422. doi:10.1038/nm.2538 22064431
   PubMed Web of Science ®Google Scholar
• Arend WP , Palmer G , Gabay C . IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev . 2008;223:20–38. doi:10.1111/j.1600-065X.2008.00624.x 18613828
   PubMed Web of Science ®Google Scholar
• De Nardo D , Latz E . NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol . 2011;32(8):373–379. doi:10.1016/j.it.2011.05.004 21733753
   PubMed Web of Science ®Google Scholar
• Stienstra R , van Diepen JA , Tack CJ , et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA . 2011;108(37):15324–15329. doi:10.1073/pnas.1100255108 21876127
   PubMed Web of Science ®Google Scholar
• Duewell P , Kono H , Rayner KJ , et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature . 2010;464(7293):1357–1361. doi:10.1038/nature08940 20428172
   PubMed Web of Science ®Google Scholar
• He J , Yang Y , Peng DQ . Monosodium urate (MSU) crystals increase gout associated coronary heart disease (CHD) risk through the activation of NLRP3 inflammasome. Int J Cardiol . 2012;160(1):72–73. doi:10.1016/j.ijcard.2012.05.083 22726397
   PubMed Web of Science ®Google Scholar
• Xiao H , Lu M , Lin TY , et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation . 2013;128(6):632–642. doi:10.1161/CIRCULATIONAHA.113.002714 23838163
   PubMed Web of Science ®Google Scholar
• Tschopp J , Schroder K . NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol . 2010;10(3):210–215. doi:10.1038/nri2725 20168318
   PubMed Web of Science ®Google Scholar
• Giacco F , Brownlee M . Oxidative stress and diabetic complications. Circ Res . 2010;107(9):1058–1070. doi:10.1161/CIRCRESAHA.110.223545 21030723
   PubMed Web of Science ®Google Scholar
• Feng H , Gu J , Gou F , et al. High glucose and lipopolysaccharide prime NLRP3 inflammasome via ROS/TXNIP pathway in mesangial cells. J Diabetes Res . 2016;2016:6973175. doi:10.1155/2016/6973175 26881256
   PubMed Web of Science ®Google Scholar
• Shi H , Zhang Z , Wang X , et al. Inhibition of autophagy induces IL-1β release from ARPE-19 cells via ROS mediated NLRP3 inflammasome activation under high glucose stress. Biochem Biophys Res Commun . 2015;463(4):1071–1076. doi:10.1016/j.bbrc.2015.06.116 26102024
   PubMed Web of Science ®Google Scholar
• Ward R , Ergul A . Relationship of endothelin-1 and NLRP3 inflammasome activation in HT22 hippocampal cells in diabetes. Life Sci . 2016;159:97–103. doi:10.1016/j.lfs.2016.02.043 26883974
   PubMed Web of Science ®Google Scholar
• Wu J , Li X , Zhu G , Zhang Y , He M , Zhang J . The role of Resveratrol-induced mitophagy/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered by mitochondrial ROS. Exp Cell Res . 2016;341(1):42–53. doi:10.1016/j.yexcr.2016.01.014 26825654
   PubMed Web of Science ®Google Scholar
• Takeda Y , Fujita Y , Honjo J , et al. Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. Diabetologia . 2012;55(2):404–412. doi:10.1007/s00125-011-2365-4 22072158
   PubMed Web of Science ®Google Scholar
• Terasaki M , Nagashima M , Nohtomi K , et al. Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin’s actions in nondiabetic and diabetic apolipoprotein E-null mice. PLoS One . 2013;8(8):e70933. doi:10.1371/journal.pone.0070933 23967137
   PubMed Web of Science ®Google Scholar
• Nakano K , Egashira K , Ohtani K , et al. Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice. Atherosclerosis . 2008;196(1):172–179. doi:10.1016/j.atherosclerosis.2007.03.036 17481639
   PubMed Web of Science ®Google Scholar
• Tian Y , Chen T , Wu Y , et al. Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms. Cardiovasc Diabetol . 2017;16(1):140. doi:10.1186/s12933-017-0624-5 29084546
   PubMed Web of Science ®Google Scholar
• Wang X , Liu W , Wu Y , et al. C-reactive protein reduces protein S-nitrosylation in endothelial cells. Mol Cell Biochem . 2013;375(1–2):131–138. doi:10.1007/s11010-012-1535-0 23224322
   PubMed Web of Science ®Google Scholar
• Sun X , Icli B , Wara AK , et al. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest . 2012;122(6):1973–1990. doi:10.1172/JCI61495 22622040
   PubMed Web of Science ®Google Scholar
• Robinson JG , Davidson MH . Can we cure atherosclerosis? Rev Cardiovasc Med . 2018;19(S1):S20–S24.30207554
   PubMed Web of Science ®Google Scholar
• Sharma A , Tate M , Mathew G , Vince JE , Ritchie RH , de Haan JB . Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol . 2018;9:114. doi:10.3389/fphys.2018.00114 29515457
   PubMed Web of Science ®Google Scholar
• Lee J , Wan J , Lee L , Peng C , Xie H , Lee C . Study of the NLRP3 inflammasome component genes and downstream cytokines in patients with type 2 diabetes mellitus with carotid atherosclerosis. Lipids Health Dis . 2017;16(1):217. doi:10.1186/s12944-017-0565-8 29151018
   PubMed Web of Science ®Google Scholar
• Wu M , Han W , Song S , et al. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Mol Cell Endocrinol . 2018;478:115–125. doi:10.1016/j.mce.2018.08.002 30098377
   PubMed Web of Science ®Google Scholar
• Lee HM , Kim JJ , Kim HJ , Shong M , Ku BJ , Jo EK . Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes . 2013;62(1):194–204. doi:10.2337/db12-0863 23086037
   PubMed Web of Science ®Google Scholar
• Vandanmagsar B , Youm YH , Ravussin A , et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med . 2011;17(2):179–188. doi:10.1038/nm.2279 21217695
   PubMed Web of Science ®Google Scholar
• Gaudreault N , Kumar N , Posada JM , et al. ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium. Arterioscler Thromb Vasc Biol . 2012;32(2):264–272. doi:10.1161/ATVBAHA.111.238964 22053073
   PubMed Web of Science ®Google Scholar
• Gower RM , Wu H , Foster GA , et al. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol . 2011;31(1):160–166. doi:10.1161/ATVBAHA.110.215434 21030716
   PubMed Web of Science ®Google Scholar
• Wu H , Gower RM , Wang H , et al. Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation . 2009;119(20):2708–2717. doi:10.1161/CIRCULATIONAHA.108.823740 19433759
   PubMed Web of Science ®Google Scholar
• Verginelli F , Adesso L , Limon I , et al. Activation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1beta. Oncotarget . 2015;6(41):43216–43229. doi:10.18632/oncotarget.6456 26646450
   PubMedGoogle Scholar
• Chang WC , Chen CH , Lee MF , et al. Chlorogenic acid attenuates adhesion molecules upregulation in IL-1beta-treated endothelial cells. Eur J Nutr . 2010;49(5):267–275. doi:10.1007/s00394-009-0083-1 19937041
   PubMed Web of Science ®Google Scholar
• Jiang T , Jiang D , Zhang L , Ding M , Zhou H . Anagliptin ameliorates high glucose-induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1. Mol Immunol . 2019;107:54–60. doi:10.1016/j.molimm.2019.01.006 30660990
   PubMed Web of Science ®Google Scholar